Heyholder
‹ Activism Filings

CELL BIOTECH CO ., LTD Q3 consolidated operating profit KRW 2.0 billion, down 9.4% YoY; net loss

CELL BIOTECH CO ., LTD· Preliminary Earnings

AI summary · Not investment advice

Q3 consolidated revenue was KRW 14.8 billion, down 3.3% YoY and 6.1% QoQ, with operating profit of KRW 2.0 billion, down 9.4% YoY and up 22.4% QoQ.

Operating profit · current quarter

KRW 2.0 billion

Key facts

Revenue (current quarter)
KRW 14.8 billion
Net income (current quarter)
KRW -4.3 billion
Operating profit change vs. prior-year quarter
-9.4%
Revenue change vs. prior-year quarter
-3.3%
Net income change vs. prior-year quarter
Turned to loss
Period
Jul 1, 2026 – Oct 31, 2026Current period as written in the source
Basis
Consolidated
Revenue (previous quarter)
KRW 15.8 billion
Revenue (prior-year quarter)
KRW 15.4 billion
Revenue change vs. previous quarter
-6.1%
Revenue (year to date)
KRW 45.3 billion
Operating profit (previous quarter)
KRW 1.6 billion
Operating profit (prior-year quarter)
KRW 2.2 billion
Operating profit change vs. previous quarter
22.4%
Operating profit (year to date)
KRW 6.8 billion
Net income (previous quarter)
KRW 3.6 billion
Net income (prior-year quarter)
KRW 3.4 billion
Net income change vs. previous quarter
Turned to loss
Net income (year to date)
KRW 4.7 billion
Net income attributable to owners (current quarter)
KRW -4.3 billion

Commentary

AI commentary · Not investment advice

What happened

Cell Biotech released its preliminary (not yet final) consolidated results for the 3 months from July to October 2026. Revenue was KRW 14.848 billion and operating profit was KRW 2.007 billion. Net income was a loss of KRW 4.268 billion. Net income attributable to the parent company's owners was also a loss of KRW 4.268 billion.

In the company's terms

Revenue fell 6.1% from the previous quarter (KRW 15.814 billion). It fell 3.3% from a year earlier (KRW 15.355 billion). Operating profit rose 22.4% from the previous quarter (KRW 1.640 billion). It fell 9.4% from a year earlier (KRW 2.216 billion). Net income turned to a loss from a profit of KRW 3.606 billion in the previous quarter. It also turned to a loss from a profit of KRW 3.449 billion a year earlier.

What changes for shareholders

Cumulative figures are revenue of KRW 45.260 billion, operating profit of KRW 6.833 billion and net income of KRW 4.690 billion.

Comments

No comments yet

Comments from shareholders will appear here.